EUVIMEDEUVIMED entdecken
Crossref

Nafamostat Mesylate Protects Against Acute Renal Ischemia–Reperfusion Injury by Alleviating Mitochondrial Dysfunction, Inhibiting Ferroptosis, and Regulating Proximal Tubular Cells: A Multi‐Omics Analysis

Yu Wang, Yuxuan Wu iD, Hongqian Li, Jiang Liu, Bo Chen, Ying Li, Qiaoyu Wang, Dongmei Zhang, Lan Huang, Huameng Xing, Santao Ou, Ling Xue und 1 weitere

Therapeutic Apheresis and Dialysis · 2025

DOI: 10.1002/1744-9987.70112 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Therapeutic Apheresis and Dialysis, 2025. Verfasst von Yu Wang und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Affiliated Hospital of Southwest Medical University/Sichuan Clinical Research Center for Nephropathy/Metabolic Vascular Dis…. Hauptthemen laut MEDLINE: Reperfusion Injury, Acute Kidney Injury, Ferroptosis, Mitochondria. Die Arbeit nennt 52 Literaturangaben. Gefördert von: Luzhou Science and Technology Bureau.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The present study aims to explore the role of nafamostat mesylate (NM) in ischemia–reperfusion (I/R)‐induced acute kidney injury (AKI).

Methods

Twenty‐one male rats were randomly divided into three groups: sham, I/R, and I/ R + NM groups. Acute renal I/R injury models were created in the I/R and I/ R + NM groups by right nephrectomy and clamping the left renal pedicle for 45 min. Rats in the I/ R + NM group were intraperitoneally injected with 0.75 mg/kg of NM before modeling. Blood and kidney specimens were collected at 24 h after model establishment. RNA sequencing (RNA‐seq), KEGG and GO enrichment analyses, and single‐cell sequencing were carried out to investigate the related mechanisms.

Results

The pretreatment with NM improved renal function, reduced mitochondrial damage, suppressed the accumulation of reactive oxygen species, and inhibited ferroptosis. The RNA‐seq indicated that NM induced protection by upregulating fatty acids, inhibiting inflammation, and promoting DNA repair. Proximal tubular cells were mainly affected.

Conclusion

NM protects against AKI by reducing reactive oxygen species, upregulating fatty acids, and regulating ferroptosis signaling pathways in proximal tubular cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Reperfusion InjuryAcute Kidney InjuryFerroptosisMitochondriaBenzamidinesGuanidinesAnimalsRatsMaleRats, Sprague-DawleyKidney Tubules, ProximalDisease Models, AnimalReactive Oxygen SpeciesMultiomics

Stichwörter der Autor:innen

ferroptosisnafamostat mesylateproximal tubular cellsrenal ischemia–reperfusion injurysingle‐cell sequencing

Substanzen

nafamostatBenzamidinesGuanidinesReactive Oxygen Species

Autor:innen und Institutionen

  • Department of Nephrology, Affiliated Hospital of Southwest Medical University/Sichuan Clinical Research Center for Nephropathy/Metabolic Vascular Disease Key Laboratory, Luzhou, China.
  • The Medical Center of Dujiangyan, Chengdu, China.
  • Anatomy Teaching and Research Office of Southwest Medical University, Luzhou, China.
  • Department of General Medicine, Chengdu Fifth People's Hospital, Chengdu, China.
  • Department of Nephrology, The First People's Hospital of Zigong, Zigong, China.
  • Department of Urology, Affiliated Hospital of Southwest Medical University/Sichuan Clinical Research Center for Nephropathy/Metabolic Vascular Disease Key Laboratory, Luzhou, China.

ORCID-Profile: Yuxuan Wu, Weihua Wu

Förderung

  • Luzhou Science and Technology Bureau

Zitieren

APA

Wang, Y., Wu, Y., Li, H., Liu, J., Chen, B., Li, Y., Wang, Q., Zhang, D., Huang, L., Xing, H., Ou, S., Xue, L., & Wu, W. (2025). Nafamostat Mesylate Protects Against Acute Renal Ischemia–Reperfusion Injury by Alleviating Mitochondrial Dysfunction, Inhibiting Ferroptosis, and Regulating Proximal Tubular Cells: A Multi‐Omics Analysis. Therapeutic Apheresis and Dialysis. https://doi.org/10.1002/1744-9987.70112

Vancouver

Wang Y, Wu Y, Li H, Liu J, Chen B, Li Y, et al. Nafamostat Mesylate Protects Against Acute Renal Ischemia–Reperfusion Injury by Alleviating Mitochondrial Dysfunction, Inhibiting Ferroptosis, and Regulating Proximal Tubular Cells: A Multi‐Omics Analysis. Therapeutic Apheresis and Dialysis. 2025. doi:10.1002/1744-9987.70112

BibTeX
@article{Wang2025,
  author = {Wang, Yu and Wu, Yuxuan and Li, Hongqian and Liu, Jiang and Chen, Bo and Li, Ying and Wang, Qiaoyu and Zhang, Dongmei and Huang, Lan and Xing, Huameng and Ou, Santao and Xue, Ling and Wu, Weihua},
  title = {Nafamostat Mesylate Protects Against Acute Renal Ischemia–Reperfusion Injury by Alleviating Mitochondrial Dysfunction, Inhibiting Ferroptosis, and Regulating Proximal Tubular Cells: A Multi‐Omics Analysis},
  journal = {Therapeutic Apheresis and Dialysis},
  year = {2025},
  doi = {10.1002/1744-9987.70112}
}
Kostenlos starten →